Only show
results from:

Sort results by:

Display preferences
92 results sorted by relevancy Results per page:
Algeta ASA raises NOK185m in financing round.(Brief Article)
Nordic Business Report; Sep 2, 2005; 605 Words NORDIC BUSINESS REPORT-2 September 2005-Algeta ASA raises NOK185m in financing round(C)1994-2005 M2...m2.com The Norwegian anticancer agents developer Algeta ASA said on Friday (2 September) that it had raised NOK185m...
Algeta listed on the Oslo Stock Exchange.(Algeta ASA)(Brief article)
Pharma Marketletter; Apr 2, 2007; 574 Words Algeta ASA, a Norwegian cancer therapeutics company...Norwegian kroner ($41.0 million) for Algeta. The IPO was more than two times subscribed...million kroner post-IPO. Thomas Ramdahl, Algeta's chief executive, commented: "we strongly...
Norwegian Itera gets NOK3.8m IT contract renewal.(Itera Consulting Group ASA)(Algeta ASA)(Brief article)
Nordic Business Report; Oct 12, 2009; 700+ Words ...2009 - Norwegian IT company Itera Consulting Group ASA (OSL: ITE) said today it won a NOK3.8m extension...to supply operating services to local drug developer Algeta ASA (OSL: ALGETA). The extension runs for five years. Via its next...
Norwegian Itera gets NOK3.8m IT contract renewal.(Itera Consulting Group contract with Algeta ASA )(Brief article)
Telecomworldwire; Oct 12, 2009; 660 Words ...2009 - Norwegian IT company Itera Consulting Group ASA (OSL: ITE) said today it won a NOK3.8m extension...to supply operating services to local drug developer Algeta ASA (OSL: ALGETA). The extension runs for five years. Via its next...
Algeta ASA-Company Report.
M2 Presswire; Jan 25, 2009; 492 Words ...25 January 2009-www.companiesandmarkets.com: Algeta ASA-Company Report(C)1994-2009 M2 COMMUNICATIONS...25012009 -www.companiesandmarkets.com adds new report: Algeta ASA-Company Report Private Company Reports provide up to...
PhotoCure ASA divests holding in Algeta ASA.(Brief Article)
Nordic Business Report; Sep 6, 2005; 575 Words ...BUSINESS REPORT-6 September 2005-PhotoCure ASA divests holding in Algeta ASA(C)1994-2005 M2 COMMUNICATIONS LTD http...500 shares in the anticancer agents developer Algeta ASA. The shares were sold at NOK400 per share, which...
l Norway-based Algeta ASA has said that Oystein Soug becomes CFO of Algeta.
Pharma Marketletter; May 26, 2008; 288 Words Norway-based Algeta ASA has said that Oystein Soug will become chief financial officer on June 1. Mr Soug joins the firm from the Orkla Group, where he was financial chief for SladCo.
Algeta Appoints Andrew Kay as President and Chief Executive Officer.
PR Newswire; Dec 11, 2008; 700+ Words ...Alpharadin in Advanced Prostate Cancer Algeta ASA , the Norwegian cancer therapeutics...in the New Year." About Algeta Algeta ASA is a Norwegian cancer therapeutics...Alpharadin and Algeta are trademarks of Algeta ASA. About Alpharadin Alpharadin is...
Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA.
PR Newswire; Feb 21, 2008; 700+ Words ...21 /PRNewswire-FirstCall/ -- Algeta ASA , the cancer therapeutics company...first half of 2008." About Algeta Algeta ASA is a Norwegian cancer therapeutics...Alpharadin and Algeta are trademarks of Algeta ASA. Forward-looking Statement This...
Algeta to Enroll US Patients Into Global Phase III ALSYMPCA Trial Following Successful End-of-Phase II Meeting With FDA.
PR Newswire; Feb 3, 2009; 700+ Words ...Metastases in Prostate Cancer Patients Algeta ASA , the cancer therapeutics company...link in the menu bar. About Algeta Algeta ASA is a cancer therapeutics company...Alpharadin and Algeta are trademarks of Algeta ASA. About Bone Metastases Bone is the...
Algeta Signs $800 Million (EUR560m) Global Agreement With Bayer for Development and Commercialization of Alpharadin for Bone Metastases.
PR Newswire; Sep 3, 2009; 700+ Words ...substantial majority of the costs of future development Algeta ASA , the cancer therapeutics company, announces today...release have been translated at 1 Euro: USD1.43 About Algeta Algeta ASA is a cancer therapeutics company built on world-leading...
Funding Aplenty Now Algeta's Alpharadin Bayer Deal: $800M Fixes Thorium Headache.
BIOWORLD Today; Sep 4, 2009; ; 700+ Words ...Catherine Hollingsworth, Staff Writer Algeta ASA has signed a deal valued at $800...the deal, Oslo, Norway-based Algeta will receive $61 million in cash...Andrew Kay, president and CEO of Algeta, told BioWorld Today that the deal...
Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin.
PR Newswire Europe; Aug 28, 2008; 700+ Words ...With Hormone Refractory Prostate Cancer (HRPC) Algeta ASA (OSE: ALGETA), the Norwegian cancer therapeutics company, today...the Royal Marsden Hospital in the UK. About Algeta Algeta ASA is a Norwegian cancer therapeutics company built...
Nordea cuts Norwegian Algeta rating to "sell".
Nordic Business Report; Sep 4, 2009; 633 Words ...REPORT-4 September 2009-Nordea cuts Norwegian Algeta rating to "sell"(C)1994-2009 M2 COMMUNICATIONS...Norwegian oncology radiopharmaceuticals developer Algeta ASA (OSL: ALGETA) to "sell" from "buy" after the stock yesterday...
Nordea downgrades Norwegian Algeta to "sell".
ADP News Nordic; Sep 4, 2009; 617 Words ...Norwegian oncology radiopharmaceuticals developer Algeta ASA (OSL:ALGETA) to "sell" from "buy" after the stock yesterday...then fell below stop-loss level. On Thursday, Algeta announced a global licensing agreement, valued at...
DnB NOR affirms "buy" on Algeta.
Nordic Business Report; Sep 7, 2009; 633 Words ...REPORT-7 September 2009-DnB NOR affirms "buy" on Algeta(C)1994-2009 M2 COMMUNICATIONS http://www...NOK90-NOK100 on Norwegian drug development company Algeta ASA (OSL: ALGETA), and considers the potential should be over NOK300...
Norwegian Algeta pretax loss widens in Q3 '09.(Financial report)(Brief article)
Nordic Business Report; Nov 13, 2009; 688 Words ...NORDIC BUSINESS REPORT-13 November 2009-Norwegian Algeta pretax loss widens in Q3 '09(C)1994-2009 M2...Norwegian oncology radiopharmaceuticals developer Algeta ASA (OSL: ALGETA) said today its pretax loss widened to NOK51m in...
Norwegian Algeta inks USD800m alliance with Bayer for cancer drug Alpharadin.
Nordic Business Report; Sep 3, 2009; 700+ Words ...NORDIC BUSINESS REPORT-3 September 2009-Norwegian Algeta inks USD800m alliance with Bayer for cancer drug Alpharadin...Norwegian oncology radiopharmaceuticals developer Algeta ASA (OSL: ALGETA) today announced a global agreement for its drug...
Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer.(Clinical report)
PR Newswire Europe; Jan 14, 2009; 700+ Words ...Indications OSLO, Norway, January 14 /PRNewswire/ -- Algeta ASA (OSE: ALGETA), the cancer therapeutics company, announces that...successful completion of the phase II program also supports Algeta's strategy for targeting Alpharadin at patients...
DnB NOR Markets bullish on Algeta, sees NOK 300 potential.
ADP News Nordic; Sep 7, 2009; 622 Words ...NOK 90-100 on Norwegian drug development company Algeta ASA (OSL:ALGETA), and considers the potential should be over NOK 300 a share. The broker considers the contract, which Algeta recently landed from German major Bayer AG (ETR...
92 results: 1 | 2 | 3 | 4 | 5

Find articles, research, and archives